Skip to Content


In the US, Gemzar (gemcitabine systemic) is a member of the drug class antimetabolites and is used to treat Breast Cancer, Breast Cancer - Metastatic, Non-Small Cell Lung Cancer, Ovarian Cancer and Pancreatic Cancer.

US matches:

UK matches:

Ingredient matches for Gemzar


Gemcitabine is reported as an ingredient of Gemzar in the following countries:

  • Cyprus
  • Ecuador
  • Egypt
  • Lebanon
  • Paraguay
  • Peru
  • Poland
  • Singapore
  • Tunisia
  • Uruguay

Gemcitabine hydrochloride (a derivative of Gemcitabine) is reported as an ingredient of Gemzar in the following countries:

  • Australia
  • Brazil
  • Chile
  • China
  • Colombia
  • Czech Republic
  • France
  • Germany
  • Hong Kong
  • Iceland
  • Indonesia
  • Italy
  • Japan
  • Kuwait
  • Lithuania
  • Malaysia
  • Malta
  • Mexico
  • Norway
  • Pakistan
  • Russian Federation
  • Serbia
  • South Africa
  • Sweden
  • Taiwan
  • United Kingdom
  • United States
  • Venezuela
  • Vietnam

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.